221 related articles for article (PubMed ID: 29331371)
21. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
[TBL] [Abstract][Full Text] [Related]
22. Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study.
Wang M; Bi Y; Jin Y; Zheng ZJ
JCO Glob Oncol; 2024 May; 10():e2300393. PubMed ID: 38754054
[TBL] [Abstract][Full Text] [Related]
23. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.
Hjortkjær M; Malik Aagaard Jørgensen M; Waldstrøm M; Ørnskov D; Søgaard-Andersen E; Jakobsen A; Dahl-Steffensen K
Int J Gynecol Cancer; 2019 Jan; 29(1):166-173. PubMed ID: 30640700
[TBL] [Abstract][Full Text] [Related]
24. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413
[TBL] [Abstract][Full Text] [Related]
25. Population attributable fractions for ovarian cancer in Swedish women by morphological type.
Granström C; Sundquist J; Hemminki K
Br J Cancer; 2008 Jan; 98(1):199-205. PubMed ID: 18071361
[TBL] [Abstract][Full Text] [Related]
26. Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.
Nagle CM; Olsen CM; Webb PM; Jordan SJ; Whiteman DC; Green AC; ;
Eur J Cancer; 2008 Nov; 44(16):2477-84. PubMed ID: 18707869
[TBL] [Abstract][Full Text] [Related]
27. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
Kim SJ; Rosen B; Fan I; Ivanova A; McLaughlin JR; Risch H; Narod SA; Kotsopoulos J
Br J Cancer; 2017 Mar; 116(7):964-971. PubMed ID: 28208158
[TBL] [Abstract][Full Text] [Related]
28. Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study.
Soisson S; Ganz PA; Gaffney D; Rowe K; Snyder J; Wan Y; Deshmukh V; Newman M; Fraser A; Smith K; Herget K; Hanson HA; Wu YP; Stanford J; Werner TL; Setiawan VW; Hashibe M
Gynecol Oncol; 2018 Mar; 148(3):499-506. PubMed ID: 29289418
[TBL] [Abstract][Full Text] [Related]
29. The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.
Shafrir AL; Rice MS; Gupta M; Terry KL; Rosner BA; Tamimi RM; Hecht JL; Tworoger SS
Gynecol Oncol; 2016 Dec; 143(3):628-635. PubMed ID: 27720231
[TBL] [Abstract][Full Text] [Related]
30. The nature of early-stage endometrial cancer recurrence-A national cohort study.
Jeppesen MM; Jensen PT; Gilså Hansen D; Iachina M; Mogensen O
Eur J Cancer; 2016 Dec; 69():51-60. PubMed ID: 27816832
[TBL] [Abstract][Full Text] [Related]
31. Incidence and potential predictors of thromboembolic events in epithelial ovarian carcinoma patients during perioperative period.
Zhou Q; Zhu C; Shen Z; Zhang T; Li M; Zhu J; Qin J; Xie Y; Zhang W; Chen R; Wang G; Qian L; Wu D; Nashan B; Zhou Y
Eur J Surg Oncol; 2020 May; 46(5):855-861. PubMed ID: 32001042
[TBL] [Abstract][Full Text] [Related]
32. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
Hemminki K; Aaltonen L; Li X
Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
[TBL] [Abstract][Full Text] [Related]
33. Epithelial ovarian cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study.
Aschebrook-Kilfoy B; Ward MH; Gierach GL; Schatzkin A; Hollenbeck AR; Sinha R; Cross AJ
Eur J Cancer Prev; 2012 Jan; 21(1):65-72. PubMed ID: 21934624
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for ovarian cancers with and without microsatellite instability.
Segev Y; Pal T; Rosen B; McLaughlin JR; Sellers TA; Risch HA; Zhang S; Ping S; Narod SA; Schildkraut J
Int J Gynecol Cancer; 2013 Jul; 23(6):1010-5. PubMed ID: 23748177
[TBL] [Abstract][Full Text] [Related]
35. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
[TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
Brasky TM; Felix AS; Cohn DE; McMeekin DS; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Park KJ; Ali S; Brinton LA
J Natl Cancer Inst; 2017 Mar; 109(3):1-10. PubMed ID: 28376204
[TBL] [Abstract][Full Text] [Related]
37. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
38. Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):104-109. PubMed ID: 27672055
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic features of borderline ovarian tumors in California: a population-based study.
Morris CR; Liu L; Rodriguez AO; Cress RD; Snipes K
Cancer Causes Control; 2013 Apr; 24(4):665-74. PubMed ID: 23314731
[TBL] [Abstract][Full Text] [Related]
40. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
